Validation of the Asia Pacific Colorectal Screening (APCS) score in a Western population: An alternative screening tool

Journal of Gastroenterology and Hepatology (Australia)

Volumn 31, Issue 2, 2016, Pages 370-375

  Corte, Crispin ^a,b,c   Zhang, Lora ^b   Chen, Ji ^b   Westbury, Sean ^b   Shaw, James ^b   Yeoh, Khay Guan ^d,e   Leong, Rupert ^a,b,c  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c University of Sydney   (Australia)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Colorectal cancer: clinical research

Indexed keywords

ADULT; AGE; ARTICLE; ASIA PACIFIC COLORECTAL SCREENING SCORE; BODY MASS; BODY WEIGHT; CANCER RISK; CANCER SCREENING; COLON POLYP; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; DISEASE ASSOCIATION; ETHNICITY; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX; SMOKING; SYMPTOM; TEACHING HOSPITAL; VALIDATION STUDY; ADENOMA; ADOLESCENT; AGED; ASIA; COHORT ANALYSIS; COLORECTAL NEOPLASMS; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; RISK; VERY ELDERLY; WESTERN WORLD; YOUNG ADULT;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIA; BODY WEIGHT; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK; SMOKING; WESTERN WORLD; YOUNG ADULT;

EID: 84955610554     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.13196     Document Type: Article

References (36)

1. Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010 127: 2893-917.
2. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2006. CA Cancer J. Clin. 2006; 56: 106-30.
3. Jemal A, Center MM, DeSantis C et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomarkers Prev. 2010; 19: 1893-907.
4. Sung JJ, Lau JY, Goh KL et al. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005; 6: 871-6.
5. Stryker SJ, Wolff BG, Culp CE et al. Natural history of untreated colonic polyps. Gastroenterology 1987; 93: 1009-13.
6. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med. 1993; 329: 1977.
7. Winawer S, Fletcher R, Rex D et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003; 124: 544-60.
8. Winawer SJ, Fletcher RH, Miller L et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594-642.
9. Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. Sydney: The Cancer Council Australia and Australian Cancer Network, 2005.
10. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-95.
11. Improving Outcomes in Colorectal Cancers. London: National Institute for Health and Clinical Excellence, 2004.
12. Improving Colonoscopy Services in Australia. The National Bowel Cancer Screening Program Quality Working Group, Ageing AGDoHa; 2009.
13. Sonnenberg A, Delcò F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann. Intern. Med. 2000; 133: 573-84.
14. Church J. Complications of colonoscopy. Gastroenterol. Clin. North Am. 2013; 42: 639-57.
15. Adelstein BA, Macaskill P, Turner RM et al. The value of age and medical history for predicting colorectal cancer and adenomas in people referred for colonoscopy. BMC Gastroenterol. 2011; 11: 97.
16. Adelstein BA, Macaskill P, Chan SF et al. Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review. BMC Gastroenterol. 2011; 11: 65.
17. Adelstein BA, Irwig L, Macaskill P et al. Who needs colonoscopy to identify colorectal cancer? Bowel symptoms do not add substantially to age and other medical history. Aliment. Pharmacol. Ther. 2010; 32: 270-81.
18. Levitzky BE, Brown CC, Heeren TC et al. Performance of a risk index for advanced proximal colorectal neoplasia among a racially/ethnically diverse patient population (risk index for advanced proximal neoplasia). Am. J. Gastroenterol. 2011; 106: 1099-106.
19. Schroy PC, 3rd, Coe AM, Mylvaganam SR et al. The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy. Cancer Prev. Res. (Phila.). 2012; 5: 1044-52.
20. Yeoh KG, Ho KY, Chiu HM et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011; 60: 1236-41.
21. Wang JY, Li ZT, Zhu YM et al. Utility of the Asia-Pacific colorectal screening scoring system and the presence of metabolic syndrome components in screening for sporadic colorectal cancer. World J. Gastroenterol. 2014; 20: 11394-9.
22. Kim DH, Cha JM, Shin HP et al. Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea. J. Clin. Gastroenterol. 2014.
23. Wong MC, Lam TY, Tsoi KK et al. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut. 2014; 63: 1130-6.
24. Kitahara CM, Berndt SI, de Gonzalez AB et al. Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. J. Clin. Oncol. 2013; 31: 2450-9.
25. Liu CS, Hsu HS, Li CI et al. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population. BMC Gastroenterol. 2010; 10: 51.
26. Shen Z, Wang S, Ye Y et al. Clinical study on the correlation between metabolic syndrome and colorectal carcinoma. ANZ J. Surg. 2010; 80: 331-6.
27. Organization WH. Preventing and Managing the Global Epidemic [Report of a WHO Consultation on Obesity]. Geneva: World Health Organization, 1997.
28. James PT, Leach R, Kalamara E et al. The worldwide obesity epidemic. Obes. Res. 2001; 9: 228S-33S.
29. Meynet O, Ricci JE. Caloric restriction and cancer: molecular mechanisms and clinical implications. Trends Mol. Med. 2014; 20: 419-27.
30. Tee HP, Corte C, Al-Ghamdi H et al. Prospective randomized controlled trial evaluating cap-assisted colonoscopy vs standard colonoscopy. World J. Gastroenterol. WJG 2010; 16: 3905-10.
31. Corte C, Dahlenburg L, Selby W et al. Hyoscine butylbromide administered at the cecum increases polyp detection: a randomized double-blind placebo-controlled trial. Endoscopy. 2012; 44: 917-22.
32. Lieberman DA, Rex DK, Winawer SJ et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012; 143: 844-57.
33. Lieberman DA, Weiss DG, Harford WV et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007; 133: 1077-85.
34. Cao Y, Rosner BA, Ma J et al. Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy. Int. J. Cancer. 2015.
35. Laiyemo AO, Murphy G, Albert PS et al. Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4years. Ann. Intern. Med. 2008; 148: 419-26.
36. Corte C, Zhang L, Leong R. Protocol: The Sydney Colorectal Cancer Screening Study (SuCCeSS). Sydney Local Health District: Human Research and Ethics Committee, 2014.